PCI 7 November 2023, 15:22
Thermofisher: Thu 29 February 2024, 11:15
BMG Labtech: Wed 18 September 2024, 11:55
Owen Mumford 12 January 2022, 16:46

Current Edition

Cell and Gene Therapy

Upcoming Events

PEGS Boston – 17/02/2025
NextGen BioMed – 04/02/2025
BioTrinity 2025 – January 30th 2025
Elrig R&I 2025 – 27th January 2025
Biotechnology Show 2025: 20th January 2025
Anglonordic: 16th January 2025
AI in Drug Discovery – SAE media – January 14th 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault: Wed 17 July 2024, 11:46
Aurisco – 04/02/2025

Understanding and Overcoming the Challenges of Flow Cytometry

Flow cytometry is a powerful analytical tool that is widely used throughout drug development in various capacities. With an understanding of the range of applications flow cytometry offers, it is clear why it is heavily implemented in drug discovery and development. Studies have the ability to detect the expression of cell surface and/or intracellular molecules, determine the proportion of cell types within a heterologous cell population, and analyse cell volume and size. However, the flexibility offered means goal-guided careful study design and a thorough technological understanding are required to define and inform panel selection, compensation, and gating in flow cytometry. Pirouz Daftarian at Crown Bioscience explores these requirements and highlights the need for drug developers to ensure that flow cytometry studies are purpose-driven in their design, to realise a world where patients get the right treatment at the right time.

Newcells 3 June 2024, 15:12
Novonordisk: Wed 17 July 2024, 11:22
FujiFilm 30 October 2023, 16:23
Autoscribe Mon 26 June 2023, 15:15
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
GenXPro: Mon 16 September 2024, 10:40